Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MN/Minneapolis
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Minneapolis, MN

Studies commonly pay $75 to $4,500 per completed study

1,071 clinical trials are currently recruiting participants within 30 miles of Minneapolis. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,071studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Minneapolis right now

Top 25 of 1,071 recruiting studies, sorted by proximity — each links to its official registry page

CIBMTR Research Database

Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation N/A Observational 99,999,999 participants sought
Center for International Blood and Marrow Transplant Research — Minneapolis, Minnesota (1.2 mi) · Sponsor: Center for International Blood and Marrow Transplant Research
See eligibility & contact on ClinicalTrials.gov (NCT01166009)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Abbott-Northwestern Hospital — Minneapolis, Minnesota (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospitals and Clinics of Minnesota - Minneapolis — Minneapolis, Minnesota (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Any Solid Oral Medication N/A Interventional 200 participants sought
Allina — Minneapolis, Minnesota (1.2 mi) · Sponsor: Dosentrx Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06344416)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Minnesota Oncology Hematology (MNO) ( Site 8004) — Burnsville, Minnesota (13.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
University of Minnesota Medical School — Minneapolis, Minnesota (1.2 mi) · Sponsor: Azafaros B.V.
See eligibility & contact on ClinicalTrials.gov (NCT07054515)

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Severe Tricuspid Regurgitation N/A Interventional 1,186 participants sought
Abbott Northwestern Hospital — Minneapolis, Minnesota (1.2 mi) · Sponsor: Medtronic Cardiovascular
See eligibility & contact on ClinicalTrials.gov (NCT07321899)

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Phase 1 Interventional 694 participants sought
M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200 — Minneapolis, Minnesota (1.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05005403)

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer Phase 2 Interventional 250 participants sought
Minnesota Oncology Hematology — Maple Grove, Minnesota (11.9 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06773910)

Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults

Acute Respiratory Failure N/A Observational 2,092 participants sought
Hennepin Healthcare — Minneapolis, Minnesota (1.2 mi) · Sponsor: Brian Driver
See eligibility & contact on ClinicalTrials.gov (NCT06934876)

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

Peripheral Neuropathies, Peripheral Neuropathy Due to Chemotherapy N/A Interventional 200 participants sought
Fairview Frontiers — Saint Paul, Minnesota (8.6 mi) · Sponsor: RxFunction Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06959277)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Minnesota Oncology Hematology, P.A. — Minneapolis, Minnesota (1.2 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
International Diabetes Center — Minneapolis, Minnesota (1.2 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

Neurotrophic Keratitis Phase 2 Interventional 54 participants sought
Minnesota Eye Consultants — Minneapolis, Minnesota (1.2 mi) · Sponsor: TearSolutions, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07568730)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
VitreoRetinal Surgery, PLLC. — Minneapolis, Minnesota (1.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Fairview Southdale Hospital — Edina, Minnesota (6.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression Phase 1 Interventional 198 participants sought
M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center — Minneapolis, Minnesota (1.2 mi) · Sponsor: Bayer
See eligibility & contact on ClinicalTrials.gov (NCT06217822)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
DaVita Clinical Research Edina — Edina, Minnesota (6.5 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Minneapolis, Minnesota (1.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Minneapolis, Minnesota (1.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)
Actively enrolling

Studies you may be able to join near Minneapolis

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Minneapolis

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical Research Institute

★ 4.9
825 Nicollet Mall #1135, Minneapolis, MN 55402
(612) 333-2200
"The best part of this location is that there is a dedicated bike trail past all the traffic from the western suburbs."
— Jesse Kortes, 4★

University of Minnesota Clinical Research Unit (CRU)

516 Delaware St SE, Minneapolis, MN 55455

Bright Research

★ 5.0
730 2nd Ave S #500, Minneapolis, MN 55402
(612) 345-4544
"Bright Research Partners is a joy to work with. They do amazing work, and they're a great company to partner with."
— Bob Thompson, 5★

Epidemiology Clinical Research Center

★ 5.0
1100 Washington Ave S, Minneapolis, MN 55415
(612) 626-9199

Berman Center for outcomes and clinical research

825 S 8th St, Minneapolis, MN 55404
(612) 873-6910

UMN Oral Health Clinical Research Center (OHCRC)

Malcolm Moos Health Sciences Tower, 515 Delaware St SE, Minneapolis, MN 55455

Nucleus Network Minneapolis Clinic

★ 4.3
1000 Westgate Dr #149, St Paul, MN 55114
(651) 641-2900
"Absolutely outstanding in every way. A+. Ten stars! The staff was the BEST in America! So amazing I just can’t say enough about ALL of them. So dedic…"
— Jennifer, 5★

Center for Clinical Imaging Research

★ 5.0
2021 6th St SE, Minneapolis, MN 55414
(612) 626-6900
"I get periodic scans to monitor the progress of my cancer treatment. As you can imagine it can be nerve-wracking to undergo testing that may show a l…"
— Deb Justdeb, 5★

Prism Clinical Research

1000 Westgate Dr #149, St Paul, MN 55114

Clinical trials in Minneapolis: what's recruiting

The Minneapolis area currently has 1,071 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Minneapolis, the most active research areas are:

  • Cancer & Oncology12 studies
  • Diabetes & Metabolism2 studies
  • Lungs & Breathing1 studies
  • Heart & Vascular1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Minneapolis, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Minneapolis

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Minneapolis participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Minneapolis safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Minneapolis, MN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Minneapolis?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Minneapolis?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Minneapolis.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Minneapolis typically complete one or two studies per year.

Paid clinical trials near Minneapolis

Other metros within reach

St. Paul, MN1,073 Cedar Rapids, IA585 Des Moines, IA220 Sioux Falls, SD259 Fargo, ND198 Madison, WI528 Davenport, IA43 Omaha, NE593

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Minneapolis Bladder Issues Due To Spinal Cord Injury in Minneapolis All conditions

More of MN

St. Paul1,073

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts